PIK3CA and head and neck squamous cell carcinoma: Both PI3K inhibitors BKM120 (0–5 μM) and GDC0980 (0–10 μM) effectively inhibited cellular growth dose-dependently in all HNSCC cells (Fig. 1A, Supplementary Fig. 1).